{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:47:49Z","timestamp":1770349669698,"version":"3.49.0"},"reference-count":28,"publisher":"The University of Occupational and Environmental Health, Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J UOEH"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.7888\/juoeh.43.227","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T22:13:30Z","timestamp":1622758410000},"page":"227-233","source":"Crossref","is-referenced-by-count":2,"title":["Hepatocyte Growth Factor and Primary Systemic Amyloidosis","\u809d\u7d30\u80de\u5897\u6b96\u56e0\u5b50\u3068\u539f\u767a\u6027\u5168\u8eab\u6027\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9"],"prefix":"10.7888","volume":"43","author":[{"given":"Tsukasa","family":"KARASUYAMA","sequence":"first","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"HONMA","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"KUMAMOTO","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"},{"name":"Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"SHIBATA","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuyuki","family":"WATANABE","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"SHIMAJIRI","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"ABE","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"YAMASHITA","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"HARADA","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4637","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gillmore JD, Hawkins PN & Pepys MB (1997): Amyloidosis: a review of recent diagnostic and therapeutic developments.  Br J Haematol 99(2): 245\u2212256","DOI":"10.1046\/j.1365-2141.1997.303194.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gohda E, Tsubouchi H, Nakayama H <i>et al<\/i> (1986): Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure.  Exp Cell Res 166(1): 139\u2212150","DOI":"10.1016\/0014-4827(86)90514-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gohda E, Tsubouchi H, Nakayama H <i>et al<\/i> (1988): Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure.  J Clin Invest 81(2): 414\u2212419","DOI":"10.1172\/JCI113334"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakamura T, Teramoto H & Ichihara A (1986): Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures.  Proc Natl Acad Sci U S A 83(17): 6489\u22126493","DOI":"10.1073\/pnas.83.17.6489"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Swiger KJ, Friedman EA, Brittain EL <i>et al<\/i> (2016): Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.  Amyloid 23(4): 242\u2212248","DOI":"10.1080\/13506129.2016.1242480"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Luciani M, Troncone L & Monte FD (2018): Current and future circulating biomarkers for cardiac amyloidosis.  Acta Pharmacol Sin 39(7): 1133\u22121141","DOI":"10.1038\/aps.2018.38"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hashimoto O, Harada M, Sata M <i>et al<\/i> (1995): Functional liver imaging with asialoglycoprotein receptors and serum hyaluronate in a patient with amyloidosis.  J Gastroenterol 30(3): 403\u2212407","DOI":"10.1007\/BF02347519"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Premkumar M, Rangegowda D, Vyas T <i>et al<\/i> (2017): Primary Hepatic Amyloidosis Presenting as Acute-on-Chronic Liver Failure.  ACG Case Rep J 4: e22","DOI":"10.14309\/crj.2017.22"},{"key":"9","unstructured":"9. Hoffman MS, Stein BE, Davidian MM & Rosenthal WS (1988): Hepatic amyloidosis presenting as severe intrahepatic cholestasis: a case report and review of the literature.  Am J Gastroenterol 83(7): 783\u2212785"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lachmann HJ & Hawkins PN (2006): Systemic amyloidosis.  Curr Opin Pharmacol 6(2): 214\u2212220","DOI":"10.1016\/j.coph.2005.10.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sipe JD, Benson MD, Buxbaum JN <i>et al<\/i> (2014): Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis.  Amyloid 21(4): 221\u2212224","DOI":"10.3109\/13506129.2014.964858"},{"key":"12","unstructured":"12. Kyle RA & Greipp PR (1983): Amyloidosis (AL).  Clinical and laboratory features in 229 cases.  Mayo Clin Proc 58(10): 665\u2212683"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF & Gertz MA (2003): Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.  Medicine (Baltimore) 82(5): 291\u2212298","DOI":"10.1097\/01.md.0000091183.93122.c7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Merlini G (2012): CyBorD: stellar response rates in AL amyloidosis.  Blood 119(19): 4343\u22124345","DOI":"10.1182\/blood-2012-03-413112"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Falk RH (2005): Diagnosis and management of the cardiac amyloidoses.  Circulation 112(13): 2047\u22122060","DOI":"10.1161\/CIRCULATIONAHA.104.489187"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Menke DM, Kyle RA, Fleming CR, Wolfe JT, 3rd, Kurtin PJ & Oldenburg WA (1993): Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis.  Mayo Clin Proc 68(8): 763\u2212767","DOI":"10.1016\/S0025-6196(12)60634-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Palladini G, Kyle RA, Larson DR, Therneau TM, Merlini G & Gertz MA (2005): Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis.  Amyloid 12(2): 120\u2212126","DOI":"10.1080\/13506120500107055"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Huang XH & Liu ZH (2016): The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China.  Kidney Dis (Basel) 2(1): 1\u22129","DOI":"10.1159\/000444287"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Muchtar E, Gertz MA, Kumar SK <i>et al<\/i> (2017): Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.  Blood 129(15): 2111\u22122119","DOI":"10.3410\/f.727246779.793549868"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gertz MA, Comenzo R, Falk RH <i>et al<\/i> (2005): Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u221222 April 2004.  Am J Hematol 79(4): 319\u2212328","DOI":"10.1002\/ajh.20381"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Trehan P, Gouri M, Wilfred C, Rashmi K & Mysorekar V (2017): Primary Amyloidosis \u2212 In a Case with Normal Plasma Cell Counts.  J Clin Diagn Res 11(7): ED21\u2212ED23","DOI":"10.7860\/JCDR\/2017\/26429.10241"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wechalekar AD, Gillmore JD & Hawkins PN (2016): Systemic amyloidosis.  Lancet 387(10038): 2641\u22122654","DOI":"10.1016\/S0140-6736(15)01274-X"},{"key":"23","unstructured":"23. Kyle RA & Gertz MA (1995): Primary systemic amyloidosis: clinical and laboratory features in 474 cases.  Semin Hematol 32(1): 45\u221259"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kyle RA & Bayrd ED (1975): Amyloidosis: review of 236 cases.  Medicine (Baltimore) 54(4): 271\u2212299","DOI":"10.1097\/00005792-197507000-00001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tsubouchi H, Hirono S, Gohda E <i>et al<\/i> (1989): Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.  Hepatology 9(6): 875\u2212881","DOI":"10.1002\/hep.1840090615"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Abraham J, Desport E, Rigaud C <i>et al<\/i> (2015): Hepatocyte growth factor measurement in AL amyloidosis.  Amyloid 22(2): 112\u2212116","DOI":"10.3109\/13506129.2015.1014548"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shikano M, Kushimoto H, Hasegawa H <i>et al<\/i> (2000): Usefulness of serum hepatocyte growth factor for the diagnosis of amyloidosis.  Intern Med 39(9): 715\u2212719","DOI":"10.2169\/internalmedicine.39.715"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Iwasaki T, Hamano T, Ogata A, Hashimoto N, Kitano M & Kakishita E (2002): Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma.  Br J Haematol 116(4): 796\u2212802","DOI":"10.1046\/j.0007-1048.2002.03364.x"}],"container-title":["Journal of UOEH"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/43\/2\/43_227\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T05:04:20Z","timestamp":1622869460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/43\/2\/43_227\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7888\/juoeh.43.227","relation":{},"ISSN":["0387-821X","2187-2864"],"issn-type":[{"value":"0387-821X","type":"print"},{"value":"2187-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}